USPH Q4 net loss $0.7M ($0.38/share) on $17.5M impairment; FY Adj EBITDA $77.7M; 2024 guide $80-85M

U S PHYSICAL THERAPY INC /NV

2023-FY EPS reported $1.28 revenue$604,802,000

Net income FY2023 $28.2M ($1.28/share) vs $32.2M ($2.25/share) in FY2022; non-GAAP Op Results $36.3M ($2.56/share).
Record patient visits in FY2023 of 5.0M (+11.6%); total clinics 671 as of Dec 31, 2023 (46 added, 15 closed).
Q4 2023 total net revenue $154.8M (+9.6%); gross profit $30.5M; GAAP loss per share $0.38 due to $17.5M impairment.
Board raised quarterly dividend to $0.44/share from $0.43; payable Apr 5, 2024 to record Mar 12, 2024.
2024 Adjusted EBITDA guided at $80-85M; expects to offset ~$6M Medicare rate cut via rate negotiations, volume growth, & acquisitions.

item 2.02 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

U S PHYSICAL THERAPY INC /NV reported financial results for the fourth quarter and the full year ended December 31, 2023.

Period: the fourth quarter and the full year ended December 31, 2023
Result: reported results

Exact text from the filing

On February 28, 2024, – U.S. Physical Therapy, Inc. (“USPH” or the “Company”) (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, reported results for the fourth quarter and the full year ended December 31, 2023.

View on SEC.gov

31 earnings releases filed in the last 30 days. Browse all earnings releases →

U S PHYSICAL THERAPY INC /NV filing history →

Source: SEC EDGAR

accession 0000885978-24-000005

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.